Daily Tech News, Interviews, Reviews and Updates

DOLO Controversy: Over Rs 1000 crores paid to push the pills

According to a Supreme Court petition, drug manufacturers need to answer for bribing physicians with freebies in an effort to induce them to prescribe their products. One significant instance cited in the petition was the claim that doctors were allegedly offered freebies totalling Rs 1000 crores in exchange for prescribing the medication Dolo 650 for Covid-19 users.

Senior judge DY Chandrachud heard the plea and said that “I don’t find this to be relaxing. When I had COVID, I was also asked to have the same. This is a really severe subject, “. The centre has been ordered by the judge to investigate the claims and submit a report within 10 days.

Sanjay Parikh, a senior attorney representing the Federation of Medical and Sales Representatives Association of India, said “The drug pricing authority sets the price for 500 mg of paracetamol. However, when you up the dosage to 650 mg, it exceeds the restricted price. It is being heavily pushed because of this. This was an illustration of a gift. Even when they are not necessary, additional antibiotics are available on the market and are promoted in various combinations. A legal framework is required to regulate drug compositions, “, according to India Today.

A Statutory Code of Ethical Marketing for the Pharmaceutical Industry, with Penalties, Needs to Be Established to Curb Such Practices for the Enforcement of the Fundamental Right to Health of the People of India, according to the Petition, which also added that such violations have become very common. The petition also claimed that because the current Code is voluntary, unethical behaviour has continued to rise and has been more pronounced throughout the pandemic.



Readers like you help support The Tech Outlook. When you make a purchase using links on our site, we may earn an affiliate commission. We cannot guarantee the Product information shown is 100% accurate and we advise you to check the product listing on the original manufacturer website. Thetechoutlook is not responsible for price changes carried out by retailers. The discounted price or deal mentioned in this item was available at the time of writing and may be subject to time restrictions and/or limited unit availability. Amazon and the Amazon logo are trademarks of Amazon.com, Inc. or its affiliates Read More
You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More